Free Trial

Outset Medical (OM) Stock Price, News & Analysis

+0.08 (+2.17%)
(As of 10:21 AM ET)
Today's Range
50-Day Range
52-Week Range
93,707 shs
Average Volume
1.19 million shs
Market Capitalization
$194.47 million
P/E Ratio
Dividend Yield
Price Target

Outset Medical MarketRank™ Stock Analysis

Analyst Rating
2.33 Rating Score
47.2% Upside
$5.42 Price Target
Short Interest
18.27% of Shares Sold Short
Dividend Strength
News Sentiment
0.02mentions of Outset Medical in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$78,934 Sold Last Quarter
Proj. Earnings Growth
From ($2.23) to ($1.73) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.92 out of 5 stars

Medical Sector

811th out of 921 stocks

Electromedical Equipment Industry

15th out of 18 stocks

OM stock logo

About Outset Medical Stock (NASDAQ:OM)

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Stock Price History

OM Stock News Headlines

Outset Medical, Inc. (NASDAQ:OM) CFO Sells $13,830.54 in Stock
RBC Capital Keeps Their Hold Rating on Outset Medical (OM)
Why Outset Medical Is Rising In Pre-market?
See More Headlines
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Electromedical equipment
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
6 Analysts


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$130.38 million
Book Value
$1.80 per share


Free Float
Market Cap
$190.33 million
Not Optionable
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

OM Stock Analysis - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares.
View OM analyst ratings
or view top-rated stocks.

What is Outset Medical's stock price target for 2024?

6 brokers have issued twelve-month price objectives for Outset Medical's shares. Their OM share price targets range from $3.00 to $6.00. On average, they predict the company's stock price to reach $5.42 in the next twelve months. This suggests a possible upside of 47.2% from the stock's current price.
View analysts price targets for OM
or view top-rated stocks among Wall Street analysts.

How have OM shares performed in 2024?

Outset Medical's stock was trading at $5.41 at the beginning of 2024. Since then, OM shares have decreased by 32.0% and is now trading at $3.68.
View the best growth stocks for 2024 here

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024.
View our OM earnings forecast

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) announced its quarterly earnings results on Thursday, October, 12th. The company reported ($0.71) EPS for the quarter, beating the consensus estimate of ($0.74) by $0.03. Outset Medical had a negative net margin of 134.93% and a negative trailing twelve-month return on equity of 120.67%.

What ETFs hold Outset Medical's stock?

ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT).Procure Disaster Recovery Strategy ETF (FEMA).

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.2 million.

When did Outset Medical IPO?

Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (5.60%), Assenagon Asset Management S.A. (1.83%), Acadian Asset Management LLC (1.51%), Bellevue Group AG (1.11%), GSA Capital Partners LLP (1.05%) and Lazard Asset Management LLC (1.01%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Marc Nash, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter and Steven S Williamson.
View institutional ownership trends

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OM) was last updated on 5/22/2024 by Staff

From Our Partners